Sales and Marketing

Showing 15 posts of 11528 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …
bayer_cross_2

FDA approves first new drug for liver cancer in decade

April 28, 2017 Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …
thorkil_kastberg_christensen_provided_photo

SAB Biotherapeutics moves to bolster board

April 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …
head-196541_960_720

Mental health: Time for a new kind of therapy?

April 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mental health

It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …
eyal-desheh

Teva has another high profile role to fill

April 27, 2017 Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …

ABPI calls for a “world-class NHS” with 2017 General Election Manifesto

April 27, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election

With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …
astrazeneca_building_white

AZ’s Tagrisso continues successes with EU approval

April 26, 2017 Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

FDA condemns 14 companies selling fraudulent cancer ‘cures’ online

April 26, 2017 Research and Development, Sales and Marketing Cancer, FDA

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …
shutterstock_92671375

Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017 Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …
pharmafocus_may_cover

The May 2017 issue of Pharmafocus is now live!

April 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus

The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …

Rasna Therapeutics appoints new CEO

April 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …
uk_location_in_the_eu_2016

Pharma industry calls for EMA relocation by June in open EFPIA letter

April 25, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …

EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza

April 25, 2017 Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy

Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …
mental-health-2019924_640

Five crucial facts about mental health

April 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
lavalbldg1806696_853705

Psoriasis drug Siliq will be cheapest in class, Valeant reveals

April 24, 2017 Sales and Marketing Siliq, Valeant, psoriasis

Canadian pharmaceutical firm Valeant has announced the list price for its psoriasis treat Siliq (brodalumab) will stand at $3,500 a …
The Gateway to Local Adoption Series

Latest content


Five Facts about COPD

October 11, 2026